As Healthscope slides into receivership after nearly 18 months of high-stakes negotiations, it’s not local deals junkie David Di Pilla who is calling the shots but a secretive London-based hedge fund.
Street Talk can reveal Polus’ dealmakers are expected to land in Australia next week to meet with key decision makers at Healthscope, after cornering about $300 million of its $1.6 billion debt. That holding makes it one of Healthscope’s biggest lenders – miles ahead of rivals like Josh Friedman’s Canyon Partners which owns about $50 million to $100 million – and gives it considerable weight in the vote that would be needed to approve or block any asset sales from the receivership.